Cancer Treatment Denied by Insurance? How to Appeal Fast

When cancer treatment is denied by an insurance company, the stakes could not be higher. Yet cancer treatment denials happen regularly — and most patients do not know they have powerful legal rights to challenge them immediately. Federal law gives cancer patients the right to an expedited 72-hour appeal decision, External Independent Review: Complete Guide" class="auto-link">external review by a board-certified oncologist, and protection under multiple ACA provisions. This guide gives you the fastest path to a successful appeal.

Why Insurers Deny Cancer Treatment

Cancer treatment denials follow well-documented patterns that are frequently overturned on appeal.

• "Chemotherapy or immunotherapy is experimental": Cutting-edge cancer therapies including CAR-T, PD-1 inhibitors (pembrolizumab, nivolumab), ADC therapies, and bispecific antibodies are denied as investigational even when FDA-approved for specific indications. For FDA-approved therapies used within approved indications, this classification is factually wrong.
• "Off-label use not covered": Many FDA-approved cancer drugs are used off-label for related cancer types. Insurers deny off-label oncology use even when supported by NCCN guidelines and standard clinical practice. More than 40 states require coverage of off-label cancer drugs listed in recognized compendia.
• "Clinical trial treatment not covered": ACA plans must cover routine costs of participation in approved trials under ACA Section 2709 (42 U.S.C. § 300gg-8), but insurers frequently deny these costs incorrectly.
• "Surgery denied or delayed": Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization requirements for cancer surgery cause dangerous delays even when surgery is clearly the standard of care per NCCN guidelines.
• "Genetic testing denied": BRCA, EGFR, KRAS, PD-L1, and other companion diagnostic tests are denied, blocking access to targeted therapies that depend on those test results.
• "Oral chemotherapy coverage disparity": More than 40 states have oral chemotherapy parity laws requiring equal coverage for oral and IV chemotherapy — plans that cover IV but deny oral formulations may be violating state law.

How to Appeal a Cancer Treatment Denial

Step 1: Request Expedited Review Immediately

The moment you receive a denial, file for an expedited internal appeal in writing and by phone simultaneously. Under ACA regulations (45 CFR § 147.136) and ERISA (29 CFR § 2560.503-1), you are entitled to a decision within 72 hours when standard timelines would jeopardize your health. Cancer treatment always qualifies. Document the medical urgency in measurable terms: tumor progression rate, stage at current imaging, and your oncologist's timeline for treatment initiation.

Step 2: Identify the Denial Basis and Request the Clinical Policy Document

Read your denial letter and identify the exact reason code and the clinical policy applied. Request the complete claims file including the reviewer's notes and the clinical policy bulletin. Compare the insurer's specific criteria against the NCCN Clinical Practice Guideline for your cancer type — discrepancies between the plan's internal criteria and NCCN recommendations are your primary appeal argument.

Step 3: Engage Your Oncologist to Lead the Appeal

Your oncologist is your most powerful ally. Ask them to write a detailed letter of medical necessity that explains your specific cancer, stage, molecular/biomarker profile, and why the specific treatment was chosen; cites NCCN guidelines or other evidence supporting the recommended treatment with the Category evidence level; explains why alternative treatments are not appropriate for your specific molecular presentation; communicates the medical urgency and clinical consequences of delay in measurable terms; and requests a peer-to-peer review with the insurer's medical director. Peer-to-peer conversations frequently reverse cancer denials that paper appeals do not.

Step 4: Address the "Experimental" Argument With Documentation

If treatment is denied as experimental or investigational, your appeal must include: FDA approval documentation for the specific drug or therapy and your indication; NCCN Compendium listing for off-label uses; published clinical trial data supporting efficacy for your cancer type (systematic reviews, randomized controlled trials, major Phase III data); and documentation of adoption at NCI-designated cancer centers as standard practice. For companion diagnostic denials, frame the test as a prerequisite to covered treatment — the diagnostic result determines which FDA-approved therapy is appropriate.

Step 5: Submit the Internal Appeal and Escalate if Needed

Submit all supporting evidence simultaneously. Keep delivery records via certified mail and the insurer's portal. If the internal appeal fails, file for external review immediately — external review by a board-certified oncologist is free, binding on the insurer, and typically resolved within 45 days. Also contact the Patient Advocate Foundation (800-532-5274) and the Cancer Legal Resource Center (866-843-2572) for free advocacy assistance.

What to Include in Your Appeal

• Denial letter with reason codes and policy provision citations
• NCCN Clinical Practice Guideline excerpt for your cancer type showing Category evidence level for your treatment
• FDA approval documentation for your specific drug and indication
• Oncologist's comprehensive letter of medical necessity with NCCN citations and specific biomarker data
• Complete biomarker testing results (PD-L1 IHC, MSI/MMR, TMB, EGFR, ALK, KRAS, and other relevant markers)
• Prior treatment history with dates, regimens, documented responses, and reasons for discontinuation
• Pathology reports confirming diagnosis, histology, and staging
• Peer-reviewed clinical trial publications supporting the treatment for your specific indication and molecular profile
• ECOG or Karnofsky performance status documentation
• State oral chemotherapy parity law citation if applicable to your plan type

Fight Back With ClaimBack

Cancer treatment denials require urgent, evidence-based appeals citing NCCN guidelines, FDA approval status, state oral chemotherapy parity laws, and ACA and ERISA appeal rights. Every day of delay in cancer care matters. ClaimBack generates a professional appeal letter in 3 minutes — with the urgency and clinical precision cancer appeals demand.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal